Dr. Lipinski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
650 Peter Jefferson Pkwy
Ste 100
Charlottesville, VA 22911Phone+1 434-293-4072Fax+1 434-293-4265
Education & Training
MedStar Health/Georgetown-Washington Hospital CenterFellowship, Interventional Cardiology, 2013 - 2015
University of Virginia Medical CenterFellowship, Cardiovascular Disease, 2008 - 2013
University of VirginiaPhD, Molecular Physiology and Biological Physics, 2008 - 2012- University of Virginia Medical CenterResidency, Internal Medicine, 2006 - 2008
Virginia Commonwealth University School of MedicineClass of 2006- Stanford UniversityBS, Biological Sciences, 1996 - 2000
Certifications & Licensure
VA State Medical License 2006 - 2026
DC State Medical License 2013 - 2024- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 38 citationsRationale and design of the Virginia Commonwealth University–Anakinra Remodeling Trial‐3 (VCU‐ART3): A randomized, placebo‐controlled, double‐blinded, multicenter studyBenjamin W. Van Tassell, Michael J. Lipinski, Darryn L. Appleton, Charlotte S. Roberts, Michael C. Kontos
Clinical Cardiology. 2018-08-01 - 151 citationsInterleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.Antonio Abbate, Cory R. Trankle, Leo F. Buckley, Michael J. Lipinski, Darryn L. Appleton
Journal of the American Heart Association. 2020-03-03 - 79 citationsComparison of conventional and high-sensitivity troponin in patients with chest pain: A collaborative meta-analysisMichael J. Lipinski, Nevin C. Baker, Ricardo O. Escarcega, Rebecca Torguson, Fang Chen
American Heart Journal. 2015-01-01
Authored Content
- The PREVENT Trial: Vulnerable Plaque Is BackApril 2024
- FDA Cardiovascular Device News UpdateApril 2018
- FDA Cardiovascular Device News UpdateApril 2018
Press Mentions
- A Rapid Transformation for Covid’s Long HaulNovember 4th, 2020
Important Interventional Trials from ESC Congress 2019October 7th, 2019- Important Trial Results for Interventional Cardiology from ACC.19May 13th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
